HOW IT WORKS
The Sensydia Cardiac Performance System™ (CPS) is the only hemodynamic monitoring platform that is trained to gold-standard accuracy in a non-invasive system. This clinical breakthrough is enabled by:
Broad-band, proprietary acoustic and ECG sensors.
Acoustic and ECG signals are collected and analyzed for temporal, electrical and spectral characteristics identified from a decade of research and development.
Proprietary machine learning derived algorithms use the validated temporal, electrical and spectral classifiers to provide validated hemodynamic measurements.
Using machine learning, CPS can be trained to almost any standard measurement and methodology.
The CPS reports measurement results in real-time and sends them to the cloud.
DESIGNED TO SIMPLIFY HEMODYNAMIC MEASUREMENT
Designed to deliver gold-standard accuracy enabled by sensor design, advanced signal processing, and machine learning
GOLD STANDARD ACCURACY
Our safe and versatile design is suitable for the ICU, ER, operating room, clinic, office, and even home care settings
BROAD MEASUREMENT CAPABILITY
The CPS provides multiple measurements in a single platform, including Cardiac Output, Pulmonary Artery Pressure, and Ejection Fraction
The CPS can be deployed in minutes with minimal learning curve
The system is low-cost and light-weight, with minimal footprint to facilitate adoption
With Sensydia’s unique signal processing and machine learning approach, the CPS platform can be taught new hemodynamic measurement capabilities, allowing medical professionals to gather even more information on cardiac function in a single session.
While our initial development efforts are focused on providing new non-invasive hemodynamic measurement capabilities and improving accuracy in high-need populations, future iterations of the CPS will build on these capabilities with automated screening programs that detect critical cardiac anomalies and predict patient outcomes at the point of care.
OVERCOMING LIMITATIONS OF EXISTING SOLUTIONS
Today, providers are forced to choose between hemodynamic measurement methods that are accurate but invasive, or methods that are noninvasive but inaccurate.
The CPS overcomes these critical limitations by providing gold-standard accuracy in a noninvasive, portable system.
The gold standard for measuring Cardiac Output and Pulmonary Artery Pressure, but not ideal due to high cost and added risk of invasive catheterization.
NON-INVASIVE CARDIAC OUTPUT SYSTEMS
Non-invasive systems have been developed to monitor Cardiac Output, but accuracy limitations preclude their use from all but low-risk patient populations.
Can be used to measure Ejection Fraction and estimate Pulmonary Artery Pressure, but quantitative accuracy is highly operator dependent.
CPS is the only platform that can provide Cardiac Output, Pulmonary Artery Pressure, and Ejection Fraction measurements in a portable, point of care system. Unlike any hemodynamic measurement system before it, CPS can be sent home with patients and is easy enough to deploy during telemedicine visits with on-screen guidance from a physician.
Data remotely collected by CPS can be transmitted back to the physician, allowing them to monitor cardiac performance and make informed care decisions in lieu of office or hospital visits.
CPS has tremendous advantages during the COVID-19 crisis where patients with heart and pulmonary conditions are particularly vulnerable to coronavirus and cannot miss routine care. CPS allows them to be safely tested at home or away from infected populations.